LianBio ADR Price Prediction

LIANDelisted Stock  USD 2.18  0.05  2.24%   
As of today, The value of RSI of LianBio ADR's share price is at 50. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling LianBio ADR, making its price go up or down.

Oversold Vs Overbought

50

 
Oversold
 
Overbought
The successful prediction of LianBio ADR's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with LianBio ADR, which may create opportunities for some arbitrage if properly timed.
Using LianBio ADR hype-based prediction, you can estimate the value of LianBio ADR from the perspective of LianBio ADR response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in LianBio ADR to buy its stock at a price that has no basis in reality. In that case, they are not buying LianBio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

LianBio ADR after-hype prediction price

    
  USD 2.18  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Intrinsic
Valuation
LowRealHigh
1.981.982.40
Details
Naive
Forecast
LowNextHigh
2.002.002.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.162.212.25
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as LianBio ADR. Your research has to be compared to or analyzed against LianBio ADR's peers to derive any actionable benefits. When done correctly, LianBio ADR's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in LianBio ADR.

LianBio ADR After-Hype Price Prediction Density Analysis

As far as predicting the price of LianBio ADR at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in LianBio ADR or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of LianBio ADR, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

LianBio ADR Estimiated After-Hype Price Volatility

In the context of predicting LianBio ADR's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on LianBio ADR's historical news coverage. LianBio ADR's after-hype downside and upside margins for the prediction period are 2.18 and 2.18, respectively. We have considered LianBio ADR's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.18
2.18
After-hype Price
2.18
Upside
LianBio ADR is very steady at this time. Analysis and calculation of next after-hype price of LianBio ADR is based on 3 months time horizon.

LianBio ADR Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as LianBio ADR is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading LianBio ADR backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with LianBio ADR, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
55 Events / Month
13 Events / Month
In about 55 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.18
2.18
0.00 
0.00  
Notes

LianBio ADR Hype Timeline

LianBio ADR is now traded for 2.18. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. LianBio is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on LianBio ADR is about 0.0%, with the expected price after the next announcement by competition of 2.18. About 79.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. LianBio ADR recorded a loss per share of 0.82. The entity last dividend was issued on the 15th of March 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 55 days.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

LianBio ADR Related Hype Analysis

Having access to credible news sources related to LianBio ADR's direct competition is more important than ever and may enhance your ability to predict LianBio ADR's future price movements. Getting to know how LianBio ADR's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how LianBio ADR may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SNSESensei Biotherapeutics 0.05 4 per month 7.39  0.01  9.80 (13.21) 110.76 
NXTCNextCure 0.01 5 per month 0.00 (0.12) 5.22 (5.52) 21.68 
NUVBNuvation Bio 0.21 8 per month 4.53 (0.01) 9.48 (8.36) 21.30 
GRPHGraphite Bio(0.03)1 per month 0.00 (0.07) 4.79 (4.73) 14.40 
MACKMerrimack Pharmaceuticals 0.00 0 per month 0.00 (0.14) 1.89 (1.74) 7.02 
INZYInozyme Pharma(0.16)8 per month 0.00 (0.29) 5.68 (7.92) 16.62 
DAWNDay One Biopharmaceuticals 0.23 9 per month 0.00 (0.07) 3.84 (3.69) 11.44 
TERNTerns Pharmaceuticals(0.02)10 per month 0.00 (0.1) 5.68 (5.96) 34.09 
ELDNEledon Pharmaceuticals(0.19)6 per month 3.06  0.11  10.09 (4.24) 28.12 
HOOKHookipa Pharma(0.05)6 per month 0.00 (0.33) 4.05 (7.24) 15.72 
FENCFennec Pharmaceuticals(0.02)10 per month 0.00 (0.08) 5.98 (6.68) 23.48 
LRMRLarimar Therapeutics(0.49)9 per month 0.00 (0.07) 10.87 (9.55) 26.71 
VRCAVerrica Pharmaceuticals(0.02)8 per month 0.00 (0.13) 11.24 (12.50) 74.69 
FIXXHomology Medicines(0.01)2 per month 3.52  0.01  5.77 (5.61) 19.43 
NLTXNeoleukin Therapeutics(0.14)1 per month 0.00 (0.08) 4.05 (3.53) 27.84 
TILInstil Bio(1.77)9 per month 6.84  0.12  20.63 (10.89) 105.83 
ACHLAchilles Therapeutics PLC(0.03)4 per month 1.56  0.12  3.06 (2.88) 38.16 
ASMBAssembly Biosciences(0.72)7 per month 4.40 (0) 8.49 (5.34) 24.80 
ABOSAcumen Pharmaceuticals(0.15)7 per month 0.00 (0.07) 7.52 (6.67) 28.07 

LianBio ADR Additional Predictive Modules

Most predictive techniques to examine LianBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for LianBio using various technical indicators. When you analyze LianBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About LianBio ADR Predictive Indicators

The successful prediction of LianBio ADR stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as LianBio ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of LianBio ADR based on analysis of LianBio ADR hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to LianBio ADR's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to LianBio ADR's related companies.

Story Coverage note for LianBio ADR

The number of cover stories for LianBio ADR depends on current market conditions and LianBio ADR's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that LianBio ADR is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about LianBio ADR's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

LianBio ADR Short Properties

LianBio ADR's future price predictability will typically decrease when LianBio ADR's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of LianBio ADR often depends not only on the future outlook of the potential LianBio ADR's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LianBio ADR's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding107.9 M
Cash And Short Term Investments302.4 M
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Consideration for investing in LianBio Stock

If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments